原发性抗磷脂综合征伴血小板减少的临床表现与危险因素
回顾性分析北京协和医院2009至2019年127例原发性抗磷脂综合征(PAPS)住院患者,36例(28.3%)合并血小板减少。血小板减少组自身免疫性溶血性贫血、网状青斑、慢性肾脏病及aPL抗体三阳性发生率更高,补体C3、C4水平更低,aGAPSS评分更高;低补体血症是血小板减少的独立危险因素,伴血小板减少者症状再发风险较高。
要点
- PAPS患者中血小板减少多为轻中度,平均血小板计数(58.9±27.0)×10^9/L。
- 低补体血症是PAPS发生血小板减少的独立危险因素(OR=5.032,95%CI 3.118~22.095)。
- 伴血小板减少的PAPS患者aGAPSS评分更高(中位13分对9分,P=0.037),症状再发风险较高。
核心结论
- PAPS患者血小板减少多为轻中度降低。
- 低补体血症是PAPS患者发生血小板减少的危险因素。
- 伴血小板减少的PAPS患者症状再发风险较高。
研究设计与样本
- 回顾性分析2009年至2019年北京协和医院住院治疗的127例PAPS患者。
- 比较血小板减少组(36例,PLT<100×10^9/L)与血小板正常组(91例)的临床和实验室特征。
- 采用单因素和多因素Logistic回归分析筛选血小板减少的危险因素。
主要发现
- 血小板减少组中位年龄38.0(28.5,51.5)岁,女性占63.9%。
- 血小板减少组自身免疫性溶血性贫血发生率19.4%对3.3%,网状青斑16.7%对3.3%,慢性肾脏病25%对8.8%,aPL抗体三阳性61.1%对37.4%,均显著高于血小板正常组(P<0.05)。
- 血小板减少组补体C3为0.87 g/L对1.07 g/L,C4为0.12 g/L对0.18 g/L,均显著低于血小板正常组(P<0.05)。
- 血小板减少组中位aGAPSS评分为13分对9分,显著高于血小板正常组(P=0.037)。
- 两组血栓及病理性妊娠发生率差异无统计学意义(P>0.05)。
关键数值与推荐
- 血小板减少定义为PLT<100×10^9/L。
- 多因素Logistic回归显示低补体血症OR=5.032,95%CI 3.118~22.095。
临床怎么用
- 对PAPS患者应关注血小板计数,尤其合并低补体血症者。
- 伴血小板减少的PAPS患者需警惕疾病复发,加强随访监测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objectives: To cross-sectionally analyze the clinical characteristics of primary antiphospholipid syndrome (PAPS) patients with thrombocytopenia, risk factors associated with thrombocytopenia, and risk of symptom recurrence in these patients. Methods: The inpatients with PAPS were retrospectively analyzed in Peking Union Medical College Hospital from 2009 to 2019. Using the collected clinical and laboratory data, the clinical characteristics and risk of symptom recurrence in the PAPS patients with thrombocytopenia were compared with those in the PAPS patients with normal platelet counts. Univariate and multivariate logistic regression analyses were performed to screen the risk factors for thrombocytopenia. Results: In this study, 127 patients with PAPS were enrolled, of which 36 (28.3% ) had thrombocytopenia, with a median age of 38 years, and 63.9% were female. In the thrombocytopenia group, the average platelet count was (58.9±27.0) ×10(9)/L, and the prevalence of thrombosis and morbid pregnancy was not significantly different from that in the normal platelet group. However, the thrombocytopenia group had higher incidence rate of autoimmune hemolytic anemia (19.4% vs 3.3% ) , livedo reticularis (16.7% vs 3.3% ) , chronic kidney disease (25% vs 8.8% ) and antiphospholipid antibodies triple positiveness (61.1% vs 37.4% ) , lower complement levels (C3 of 0.87 g/L vs 1.07 g/L, C4 of 0.12 g/L vs 0.18 g/L, P<0.05) , and higher adjusted Global APS Score (median score of 13 vs 9, P=0.037) than the normal platelet group. In multivariate logistic regression analysis, hypocomplementemia (OR value 5.032, 95% CI 3.118-22.095) is an independent risk factor for thrombocytopenia. Conclusions: In patients with PAPS, thrombocytopenia is mostly mild to moderate. Hypocomplementemia may be the independent risk factor for thrombocytopenia in PAPS patients. The PAPS patients with thrombocytopenia may have a higher risk of symptom recurrence. 目的: 分析伴血小板减少原发性抗磷脂综合征(PAPS)的临床特征、与血小板减少相关的危险因素以及疾病复发风险。 方法: 回顾性分析2009年至2019年间于北京协和医院住院治疗的PAPS患者,比较血小板减少(PLT<100×10(9)/L)和血小板正常患者的临床和实验室检查结果,分析血小板减少患者的临床特征和未来症状再发风险,并应用单因素和多因素Logistic回归分析筛选血小板减少的危险因素。 结果: 纳入127例PAPS患者,其中36例(28.3%)合并血小板减少,中位年龄38.0(28.5,51.5)岁,女性占63.9%(13/23),平均血小板计数为(58.9±27.0)×10(9)/L。与血小板正常组(91例)相比,血小板减少组血栓及病理性妊娠发生率差异无统计学意义(P>0.05),自身免疫性溶血性贫血(19.4%对3.3%)、网状青斑(16.7%对3.3%)、慢性肾脏病变(25%对8.8%)、抗磷脂(aPL)抗体三阳性(61.1%对37.4%)发生率均显著增加(P<0.05),补体C3、C4水平显著降低(C3 0.87 g/L对1.07 g/L,C4 0.12 g/L对0.18 g/L,P值均<0.05),中位改良APS总体评分(aGAPSS)显著升高(13分对9分,P=0.037)。多因素Logistic回归分析显示,低补体血症(OR=5.032,95%CI 3.118~22.095)是发生血小板减少的危险因素。 结论: PAPS患者血小板减少多为轻中度降低。低补体血症是血小板减少的危险因素。伴血小板减少的PAPS患者再发风险较高。.
引用
- Li S, Lan XL, Cai HC, et al. [The clinical manifestations and risk factors in primary antiphospholipid syndrome with thrombocytopenia]. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 33677866. doi:10.3760/cma.j.issn.0253-2727.2021.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。